Browse Cardiovascular diseases topic

Drug therapy subtopic

Articles 1-34 out of 34 article(s) Title Author Type Date Words Prostate cancer patients on hormone therapy 'at increased heart disease risk'. Sep 23, 2009 451 Research and Markets: Cardiovascular Medicine: Review and Update for the Practitioner for Candidates for the American Board of Internal Medicine's Subspecialty Qualifying Examination. Sep 14, 2009 392 New model to find optimum time for statin therapy in diabetes patients. Aug 15, 2009 348 Statins for all--with established cardiovascular risk factors. Farham, Bridget Brief article Aug 1, 2009 260 Folic acid, pyridoxine, and cyanocobalamin combination treatment and age-related macular degeneration in women: the women's antioxidant and folic acid cardiovascular study. Author abstract Aug 1, 2009 9 New nanoparticle may revolutionise cardiovascular disease treatment. Jun 5, 2009 418 A reduction in cardiovascular risk is the main aim of most lipid-modifying therapy. Rajput, M. Chiman Report Mar 1, 2009 2845 EPIX Pharmaceuticals Announces FDA Approval of Vasovist[R] (gadofosveset trisodium). Dec 22, 2008 1197 An Obesity Drug Pipeline Report: The Development of Therapies for a Complex Disease. Oct 6, 2008 1082 Research and Markets: Cytokinetics is the First Company to Systematically Investigate the Cytoskeleton and Molecular Motors as Possible Drug Targets for Cancer and Cardiovascular Diseases. Company overview May 28, 2008 398 Effects of aqueous hop (Humulus Lupulus L.) extract on vascular reactivity in rats: mechanisms and influence of gender and hormonal status. Figard, H.; Girard, C.; Mougin, F.; Demougeot, C.; Berthelot, A. Report Mar 1, 2008 5125 NIMS' Motion Platform Treatments Potentially Decrease Cardiovascular Risk in Unfit Subjects. Jan 24, 2008 515 CardioVascular BioTherapeutics Engages The Bruckner Group To Find A Joint Commercialization Partner For Its FGF-1 Protein Treatment for Cardiovascular Disease Patients. Nov 27, 2007 860 New Medical Treatment for Women's Heart Disease Discussed in Dr. Stegmann's Publication "Holding a Woman's Heart in My Hands". Disease/Disorder overview Oct 23, 2007 647 AVI BioPharma Partner Cook Medical Announces Completion of Patient Enrollment for APPRAISAL Phase II Clinical Trial for Treatment of Cardiovascular Disease. Jul 10, 2007 408 APPRAISAL Phase II Clinical Trial for Treatment of Cardiovascular Disease Announces Completion of Patient Enrollment. Jul 9, 2007 493 The everyday medicines that can fuel obesity. Jun 25, 2007 325 The everyday medicines that can fuel obesity. Jun 25, 2007 331 Integrating fish oil with prescription heart medications. Scozzari, James S. Report Apr 1, 2007 478 TRx Pharma Introduces FOLMOR for the Treatment of Cardiovascular Disease. Feb 6, 2007 587 BioInvent Enters Collaboration With Genentech to Develop and Commercialize BioInvent's Proprietary Antibody for the Potential Treatment of Cardiovascular Diseases. Jan 12, 2007 502 How useful are [beta]-blockers in cardiovascular disease?/Kardiyovaskuler hastaliklarda [beta]-blokerler ne kadar yararli? Bangalore, Sripal; Parkar, Sanobar; Messerli, Franz H. Clinical report Dec 1, 2006 5436 CardioVascular BioTherapeutics to Present at 2006 Money Show; Co-Founder to Discuss Treatment Options for Different Types of Cardiovascular Disease. Jul 13, 2006 498 Cook Zilver Stent Receives FDA Approval for Vascular Use. Jul 5, 2006 423 CardioVascular BioTherapeutics Co-Founder to Present Seminar on New Treatment for Heart Disease; Renowned Cardiac & Thoracic Surgeon Dr. Thomas Stegmann to Introduce Novel Protein Drug Candidate. Jul 5, 2006 569 Women Surviving Cardiovascular Disease Treatment in Nation's Hospitals at Higher Rates, Says HealthGrades Study. Jun 26, 2006 544 The latest drugs on the FDA's radar: expect labeling changes for the stimulants. Waldron, Theresa Jun 1, 2006 1160 Biovail to Promote Novartis' Lescol(R) Franchise in Canada; Lescol(R) Provides Treatment Option for Patients Who Need a Statin to Reduce Cardiovascular Risk. May 19, 2006 1082 New Preclinical Data Shows Samaritan's Cardiovascular Drug Reduces Cholesterol; Cardiovascular Disease is a $15B Market Worldwide. Mar 28, 2006 396 Protecting the circulatory system. Zimmerman, Philip W. Mar 22, 2006 623 Millions more could get cholesterol drug on NHS. Nov 11, 2005 369 FDA now reviewing panel's nod to COX-2s: celecoxib garnered nearly unanimous support; vote was more divided on rofecoxib and valdecoxib. Mechcatie, Elizabeth Apr 1, 2005 1211 Rimonabant markedly improves cardiovascular risk profile. Jancin, Bruce Feb 1, 2005 681 Everolimus superior to azathioprine for cardiac allograft vasculopathy. Sep 15, 2003 457